Exercise program aims to ease joint pain in older breast cancer survivors
NCT ID NCT03955627
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tested whether a self-management program combining exercise classes and group discussions could relieve joint pain caused by aromatase inhibitors (AI) in older breast cancer survivors. Twelve women aged 60 and older who were starting AI medication took part. The program included 8 weeks of supervised Zoom sessions followed by 8 weeks of home-based exercise with coaching calls. Researchers measured pain levels and medication adherence over a year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
exercise and education program
What this could lead to
If it works, this could offer a simple, drug-free way to manage joint pain and improve medication adherence in older breast cancer survivors.
What could go wrong
This is a very small pilot study with only 12 participants, so results may not apply to everyone. The program is delivered via Zoom, which may not suit all older adults.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Wake Forest University Health Sciences
Winston-Salem, North Carolina, 27157, United States